Impact of Cytological Sampling on EGFR Mutation Testing in Stage III-IV Lung Adenocarcinoma

Objectives. There have been advances in the identification and understanding of molecular subsets of lung cancer, defined by specific oncogenic aberrations. A number of actionable genetic alterations have been identified, such as the epidermal growth factor receptor (EGFR) mutation. We aimed to esta...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Lung Cancer Int
Main Authors: Davies, Rhian Siân, Smith, Christian, Edwards, Gwenllian, Butler, Rachel, Parry, Diane, Lester, Jason Francis
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi 2017
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5359447/
https://ncbi.nlm.nih.gov/pubmed/28367333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/9614938
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares